Biofrontera Inc.
BFRI
$1.08
-$0.02-1.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 184.82% | -24.89% | -26.67% | -201.07% | 75.37% |
| Total Depreciation and Amortization | 6.28% | -6.76% | 1.37% | -0.90% | -29.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -217.17% | 370.92% | 159.75% | -572.00% | -95.02% |
| Change in Net Operating Assets | -481.48% | 2.04% | 1,760.19% | -4.63% | -96.56% |
| Cash from Operations | 37.85% | -25.55% | 26.04% | -304.82% | 15.81% |
| Capital Expenditure | 0.00% | 200.00% | 66.67% | -200.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 300,000.00% | 200.00% | 66.67% | -200.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -72.35% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -200.00% | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -- | -- | 1,459.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 177.84% | -170.08% | 232.38% | -235.88% | 301.33% |